Experienced in Ewing Sarcoma

Zan B. Shen

No. 600, Yishan Road, 
Shanghai, CN 
Experienced in Ewing Sarcoma
No. 600, Yishan Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Zan Shen practices in Shanghai, China. Shen is rated as an Experienced expert by MediFind in the treatment of Ewing Sarcoma. Their top areas of expertise are Osteosarcoma, Adult Soft Tissue Sarcoma, Bone Tumor, Lung Metastases, and Vertebroplasty.

Their clinical research consists of co-authoring 140 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Ewing Sarcoma.

Locations

No. 600, Yishan Road, Shanghai, 200233, China
Other Locations
600 Yishan Rd, Shanghai, 200233, China
No. 600, Yishan Road, Xuhui, 200233, China
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 600 Yishan Rd, Shanghai, 200233, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III Study of AL3818 (Anlotinib, Catequentinib) Hydrochloride Monotherapy in Subjects With Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma
A Phase III Study of AL3818 (Anlotinib, Catequentinib) Hydrochloride Monotherapy in Subjects With Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma
Enrollment Status: Active_not_recruiting
Publish Date: January 31, 2024
Intervention Type: Drug
Study Drugs: Anlotinib, Decarbazine
Study Phase: Phase 3

140 Total Publications

Integrated single-cell RNA-seq analysis reveals that EZH2 regulates the MIF-CD74 axis to modulate T cell activation and exhaustion in hepatocellular carcinoma.
Integrated single-cell RNA-seq analysis reveals that EZH2 regulates the MIF-CD74 axis to modulate T cell activation and exhaustion in hepatocellular carcinoma.
Journal: Journal of translational medicine
Published: May 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shen's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile